A comparative study of homoeopathic medicine with the multidrug therapy for paucibacillary leprosy treatment
Recently to find the efficacy of homoeopathic medicines in the treatment of leprosy a comparative clinical trial was conducted with MDT (Multidrug therapy). Homoeopathic medicine “Sulphur” had been chose with the Multi drug in the treatment of Paucibacillary leprosy according to WHO guidelines. 60 Borderline Tuberculoid (BT) leprosy patients had been selected out of 90 patients of age 14 years to less than 60 years under the trail. All the patients were allotted a precoded number, randomly and equally divided in two groups. One group received Paucibacillary (PB) regimen as recommended by WHO, whereas other group had been treated for 2 years with Sulphur in 200 potency in liquid orally once in week. Results documented after 2 years treatment which showed MDT therapy (PB regimen) and homoeopathic medicine were found equally effective ashistopathology of skin showed no granulomatous lesion. The group treated with Sulphur showed significant clinical sign of reappearance of normal skin colour and regain of loss of sensation of the skin lesion. Hence from the trail it was concluded that homoeopathic medicine and MD therapy (PB regimen) both equally found effective for treatment of leprosy. The patients of paucibacillary leprosy could get rid of the skin symptoms if treatment with Sulphur (is also given with MDT).
Reference: D. Chakraborty, P. Das, A.K. Dinda, U. Sengupta, T. Chakraborty, J. Sengupta, A comparative study of homoeopathic medicine- Sulphur with the Multidrug therapy in the treatment of paucibacillaryleprosy, Indian Journal of Research in Homoeopathy, Year : 2015, Volume : 9, Issue : 3, Page: 158-166.
The information provided herein is not intended to be taken as a replacement for medical advice and should not be used during any medical emergency. A Registered Medical Practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only and they do not constitute endorsements of those other sites.